We are live on ! Find out more
TI

Trexquant Investment Portfolio holdings

AUM $13.9B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+31.98%
3 Year Est. Return
+90.18%
5 Year Est. Return
+73.02%
10 Year Est. Return
+326.84%
AUM
$3.99B
AUM Growth
+$171M
Cap. Flow
+$382M
Cap. Flow %
9.58%
Top 10 Hldgs %
8.83%
Holding
1,926
New
545
Increased
445
Reduced
417
Closed
518

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$43M
2
HSY icon
Hershey
HSY
+$37.7M
3
PG icon
Procter & Gamble
PG
+$33.2M
4
STZ icon
Constellation Brands
STZ
+$31.8M
5
XYZ
Block Inc
XYZ
+$30.9M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$33.3M
2
MDB icon
MongoDB
MDB
+$26.6M
3
CVNA icon
Carvana
CVNA
+$25.4M
4
MCK icon
McKesson
MCK
+$23.4M
5
IDXX icon
Idexx Laboratories
IDXX
+$22.7M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.91%
3 Healthcare 13.95%
4 Industrials 11.05%
5 Financials 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDCX
1376
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$139K ﹤0.01%
+23,557
New +$155K
OLMA icon
1377
Olema Pharmaceuticals
OLMA
$1.01B
$138K ﹤0.01%
+11,151
New +$114K
CVII
1378
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$137K ﹤0.01%
+13,124
New +$137K
UTI icon
1379
Universal Technical Institute
UTI
$2.15B
$135K ﹤0.01%
+16,122
New +$126K
STER
1380
DELISTED
Sterling Check Corp. Common Stock
STER
$133K ﹤0.01%
+10,501
New +$136K
APYX icon
1381
Apyx Medical
APYX
$163M
$131K ﹤0.01%
+40,863
New +$190K
PDSB icon
1382
PDS Biotechnology
PDSB
$38.6M
$131K ﹤0.01%
+25,851
New +$142K
CRD.A icon
1383
Crawford & Co Class A
CRD.A
$551M
$129K ﹤0.01%
+13,822
New +$138K
VGR
1384
DELISTED
Vector Group Ltd.
VGR
$127K ﹤0.01%
11,953
-3,136
-21% -$36.4K
AMPY icon
1385
Amplify Energy
AMPY
$152M
$123K ﹤0.01%
16,739
-22,571
-57% -$156K
GLUE icon
1386
Monte Rosa Therapeutics
GLUE
$1.86B
$123K ﹤0.01%
25,657
+10,935
+74% +$70.4K
SEAT icon
1387
Vivid Seats
SEAT
$88.7M
$122K ﹤0.01%
951
-2,172
-70% -$320K
JANX icon
1388
Janux Therapeutics
JANX
$915M
$119K ﹤0.01%
+11,773
New +$136K
BEEM icon
1389
Beam Global
BEEM
$23.1M
$116K ﹤0.01%
+15,734
New +$147K
PROK icon
1390
ProKidney
PROK
$316M
$116K ﹤0.01%
+25,298
New +$242K
KVHI icon
1391
KVH Industries
KVHI
$172M
$110K ﹤0.01%
21,513
+4,714
+28% +$31.9K
BTMD icon
1392
Biote Corp
BTMD
$67.9M
$99K ﹤0.01%
+19,340
New +$114K
MG icon
1393
Mistras Group
MG
$490M
$94.8K ﹤0.01%
17,394
-10,803
-38% -$67.8K
AURA icon
1394
Aura Biosciences
AURA
$729M
$94.7K ﹤0.01%
+10,553
New +$114K
DSP icon
1395
Viant Technology
DSP
$227M
$92.1K ﹤0.01%
+16,455
New +$90.1K
NPKI
1396
NPK International
NPKI
$1.09B
$87K ﹤0.01%
+12,592
New +$72.1K
VYGR icon
1397
Voyager Therapeutics
VYGR
$184M
$84.5K ﹤0.01%
10,904
-33,348
-75% -$305K
VMD icon
1398
Viemed Healthcare
VMD
$457M
$84.4K ﹤0.01%
+12,537
New +$103K
DSKE
1399
DELISTED
Daseke, Inc. Common Stock
DSKE
$82.8K ﹤0.01%
+16,134
New +$97.4K
ALDX icon
1400
Aldeyra Therapeutics
ALDX
$95.3M
$77.7K ﹤0.01%
11,631
-3,940
-25% -$29.2K
54 55
56
57 58

Similar funds

SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return

Trexquant Investment's Q3 2023 Portfolio in Review

As of Q3 2023, Trexquant Investment held 1,926 positions worth $3.99B, up 4.5% from $3.82B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Trexquant Investment deployed $382M of net new capital in Q3 2023, opening 545 new positions and adding to 445 existing holdings. Its largest new stake was Microsoft: 130,179 shares worth $41.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Carvana, an estimated $25.4M trimmed.

  • Trexquant Investment's largest Q3 2023 buy was Microsoft: 130,179 shares worth $41.1M.
  • Trexquant Investment added most to Block Inc in Q3 2023, an estimated $30.9M increase.
  • Trexquant Investment's biggest Q3 2023 reduction was Carvana, cutting an estimated $25.4M.
  • Trexquant Investment fully exited Humana in Q3 2023, selling an estimated $33.3M.
  • Trexquant Investment's ten largest holdings make up 8.8% of its $3.99B portfolio in Q3 2023.
  • Trexquant Investment opened 545 new positions and closed 518 in Q3 2023.
  • Trexquant Investment's portfolio value rose 4.5% quarter-over-quarter to $3.99B.

Based on Trexquant Investment's 13F filing for Q3 2023, filed 13 Nov 2023.